Editorial Bureau, Author at British Herald
December 6, 2021
Home Articles posted by Editorial Bureau
Pharma/BioTech

Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses

NEW BRUNSWICK, N.J. – Johnson & Johnson (NYSE: JNJ) (the Company) today announced preliminary results from an independent study, including a subset of participants from the Janssen-sponsored COV2008 study, conducted by Dan Barouch, M.D., Ph.D., et al. of Beth Israel Deaconess Medical Center (BIDMC), which showed that a booster shot of the Johnson & Johnson
Pharma/BioTech

IMPACT 2021 R&D Day: Synthetic Lethality Provides a New Platform for Targeted Cancer Therapy

SHANGHAI – The 2nd R&D Day event of IMPACT Therapeutics (IMPACT) successfully took place in Shanghai on December 3rd (GMT+8). With the theme of “Synthetic Lethality: A New Platform for Targeted Therapy”, the event attracted nearly 300 guests offline and online. The guests were from investment institutions, pharmaceutical companies, universities,
Fintech

Xen Capital Raises US$7.5 Million Series A Led by Headline Asia to Scale Alternative Investment Platform

SINGAPORE – Xen Capital announces it has raised US$7.5 million in a Series A round led by Headline Asia (formerly known as Infinity Ventures) to scale its B2B2C alternative investment platform. Xen Capital has created an open architecture client management platform for wealth advisors and asset managers, to solve the problem of distribution at scale. Xen Capital has
Sport

China attacks potential US Olympic diplomatic boycott

BEIJING — China on Monday threatened to take “firm countermeasures” if the U.S. proceeds with a diplomatic boycott of February’s Beijing Winter Olympic Games. Foreign Ministry spokesperson Zhao Lijian accused U.S. politicians of grandstanding over the issue of not sending dignitaries to attend the events that China hopes will showcase its economic development and